The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCE INC | COM | 00032Q104 | 1,283,697 | 187,675 | SH | SOLE | 187,675 | 0 | 0 | ||
ADC THERAPEUTICS SA | SHS | H0036K147 | 1,290,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 2,207,450 | 4,900,000 | SH | SOLE | 4,900,000 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 1,258,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 1,222,199 | 118,891 | SH | SOLE | 118,891 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 911,000 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
ARAVIVE INC | COM | 03890D108 | 42,336 | 33,600 | SH | Call | SOLE | 33,600 | 0 | 0 | |
ARAVIVE INC | COM | 03890D108 | 1,085,112 | 861,200 | SH | Put | SOLE | 861,200 | 0 | 0 | |
ARCELLX INC | COMMON STOCK | 03940C100 | 7,154,816 | 226,275 | SH | SOLE | 226,275 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 5,155,080 | 57,760 | SH | SOLE | 57,760 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 4,294,200 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 5,421,789 | 650,875 | SH | SOLE | 650,875 | 0 | 0 | ||
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 3,781,860 | 1,589,017 | SH | SOLE | 1,589,017 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 898,250 | 12,500 | SH | SOLE | 12,500 | 0 | 0 | ||
BIOATLA INC | COM | 09077B104 | 975,000 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 11,394,000 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | 9,452,614 | 12,000,000 | PRN | SOLE | 12,000,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 6,467,200 | 376,000 | SH | Put | SOLE | 376,000 | 0 | 0 | |
BRIDGEBIO PHARMA INC | COM | 10806X102 | 604,288 | 35,133 | SH | SOLE | 35,133 | 0 | 0 | ||
CABALETTA BIO INC | COM | 12674W109 | 1,613,750 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 2,952,962 | 87,031 | SH | SOLE | 87,031 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 5,575,475 | 900,723 | SH | SOLE | 900,723 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 17,484,500 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 12,333,473 | 321,017 | SH | SOLE | 321,017 | 0 | 0 | ||
CONTEXT THERAPEUTICS INC | COM | 21077P108 | 428,118 | 267,574 | SH | SOLE | 267,574 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 11,498,792 | 1,050,118 | SH | SOLE | 1,050,118 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 4,082,328 | 125,148 | SH | SOLE | 125,148 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | NOTE 4.000%11/1 | 29664WAB1 | 3,441,033 | 6,925,000 | PRN | SOLE | 6,925,000 | 0 | 0 | ||
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 14,518,425 | 211,608 | SH | SOLE | 211,608 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 2,654,910 | 983,300 | SH | SOLE | 983,300 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 2,654,910 | 983,300 | SH | Put | SOLE | 983,300 | 0 | 0 | |
FIBROGEN INC | COM | 31572Q808 | 918,000 | 340,000 | SH | Call | SOLE | 340,000 | 0 | 0 | |
IMMATICS N.V | *W EXP 07/01/202 | N44445117 | 632,750 | 187,204 | SH | SOLE | 187,204 | 0 | 0 | ||
IMMATICS N.V | SHS | N44445109 | 3,462,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 4,932,200 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
INFLARX NV | COM | N44821101 | 1,071,292 | 240,200 | SH | SOLE | 240,200 | 0 | 0 | ||
INOZYME PHARMA INC | COM | 45790W108 | 4,187,504 | 751,796 | SH | SOLE | 751,796 | 0 | 0 | ||
JASPER THERAPEUTICS INC | COM | 471871103 | 653,419 | 476,948 | SH | SOLE | 476,948 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 1,604,628 | 178,292 | SH | SOLE | 178,292 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 9,631,154 | 910,317 | SH | SOLE | 910,317 | 0 | 0 | ||
LIANBIO | SPONSORED ADS | 53000N108 | 1,825,541 | 800,676 | SH | SOLE | 800,676 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 21,367,500 | 92,500 | SH | SOLE | 92,500 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 12,266,100 | 53,100 | SH | Call | SOLE | 53,100 | 0 | 0 | |
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 855,194 | 300,068 | SH | SOLE | 300,068 | 0 | 0 | ||
MINERALYS THERAPEUTICS INC | COM | 603170101 | 1,065,625 | 62,500 | SH | SOLE | 62,500 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 776,100 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 11,574,182 | 201,887 | SH | SOLE | 201,887 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 1,189,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 | N62509117 | 77,330 | 37,000 | SH | SOLE | 37,000 | 0 | 0 | ||
NLS PHARMACEUTICS LTD | SHS | H57830103 | 440,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 999,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 450,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
PRECIGEN INC | NOTE 3.500% 7/0 | 46122TAA0 | 1,507,426 | 1,500,000 | PRN | SOLE | 1,500,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 6,828,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 714,292 | 202,349 | SH | SOLE | 202,349 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 2,967,546 | 29,105 | SH | SOLE | 29,105 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 77313F114 | 13,913 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 3,408,600 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
TALARIS THERAPEUTICS INC | COM | 87410C104 | 608,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | 12,048,000 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 2,241,477 | 240,244 | SH | SOLE | 240,244 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 695,315 | 13,923 | SH | SOLE | 13,923 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 3,302,829 | 100,696 | SH | SOLE | 100,696 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 9,463,680 | 447,667 | SH | SOLE | 447,667 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 5,673,500 | 350,000 | SH | Put | SOLE | 350,000 | 0 | 0 | |
VIKING THERAPEUTICS INC | COM | 92686J106 | 4,863,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
VINCERX PHARMA INC | COM NEW | 92731L106 | 1,940,602 | 1,492,771 | SH | SOLE | 1,492,771 | 0 | 0 | ||
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 490,600 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 3,102,216 | 130,400 | SH | Call | SOLE | 130,400 | 0 | 0 | |
XENON PHARMACEUTICALS INC | COM | 98420N105 | 2,324,476 | 60,376 | SH | SOLE | 60,376 | 0 | 0 |